世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ベータニコチンアミドモノヌクレオチド（NMN）の世界市場に関する洞察、2028年までの予測

ベータニコチンアミドモノヌクレオチド（NMN）の世界市場に関する洞察、2028年までの予測


Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028

市場の分析と洞察。ベータ・ニコチンアミド・モノヌクレオチド（NMN）の世界市場 世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場は、2021年に2億5674万米ドルと評価されています。市場規模は2028年末までに... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年6月28日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場の分析と洞察。ベータ・ニコチンアミド・モノヌクレオチド（NMN）の世界市場
世界のβ-ニコチンアミドモノヌクレオチド（NMN）市場は、2021年に2億5674万米ドルと評価されています。市場規模は2028年末までに1億7542万米ドルに達し、2022年から2028年の間に20.23%のCAGRで成長すると予測されています。

世界のβ-ニコチンアミドモノヌクレオチド（NMN）の範囲とセグメント
β-ニコチンアミドモノヌクレオチド（NMN）市場は、タイプ別、用途別に区分されています。世界のベータニコチンアミドモノヌクレオチド（NMN）市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして使用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

企業別
ジーンハーバー
ハーバルマックス
ジェネックスフォーミュラ
新光和薬品
Maac10 Formulas
エッフェファーマ
ボンタック
セルフル
キングダムウェイ

タイプ別セグメント
コンテンツ≧98
コンテンツ ＜98

用途別セグメント
ヘルスケア製品
化粧品
その他

地域別セグメント
北アメリカ
米国
カナダ

アジア・パシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア

欧州
ドイツ
フランス
英国
イタリア
ロシア

中南米
メキシコ
ブラジル
アルゼンチン

中東・アフリカ
中東
アフリカ

ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1
1.2 Market by Type 1
1.3 Market by Application 2
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2
1.3.2 Health Care Products 3
1.3.3 Cosmetics 4
1.4 Study Objectives 4
1.5 Years Considered 5
2 EXECUTIVE SUMMARY 6
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7
2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8
2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9
2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9
2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10
2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12
2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12
2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12
2.6 North America 13
2.7 Europe 14
2.8 Asia-Pacific 15
2.9 Latin America 16
2.10 Middle East and Africa 17
3 COMPETITION BY MANUFACTURERS 19
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19
3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19
3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20
3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21
3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21
3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22
3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23
3.4 Analysis of Competitive Landscape 24
3.4.1 Manufacturers Market Concentration Ratio (CR5) 24
3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25
3.5 Mergers & Acquisitions, Expansion Plans 26
4 MARKET SIZE BY TYPE 27
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27
4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29
4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29
4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30
4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30
4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30
5 MARKET SIZE BY APPLICATION 32
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36
5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36
5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36
6 NORTH AMERICA 37
6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37
6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37
6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38
6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39
6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39
6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40
6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42
6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42
6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43
6.3.3 U.S. 44
6.3.4 Canada 45
7 EUROPE 46
7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46
7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46
7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47
7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48
7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48
7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49
7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51
7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51
7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52
7.3.3 Germany 54
7.3.4 France 55
7.3.5 U.K. 55
7.3.6 Italy 56
7.3.7 Russia 56
8 ASIA PACIFIC 57
8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57
8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57
8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58
8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59
8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59
8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60
8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62
8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62
8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63
8.3.3 China 65
8.3.4 Japan 66
8.3.5 Korea 67
8.3.6 India 68
8.3.7 Australia 69
8.3.8 Southeast Asia 70
9 LATIN AMERICA 71
9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71
9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71
9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72
9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73
9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73
9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74
9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76
9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76
9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77
9.3.3 Mexico 79
9.3.4 Brazil 80
9.3.5 Argentina 81
10 MIDDLE EAST AND AFRICA 82
10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82
10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82
10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83
10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84
10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84
10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85
10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87
10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87
10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88
10.3.3 Middle East 89
10.3.4 Africa 90
11 CORPORATE PROFILE 91
11.1 GeneHarbor 91
11.1.1 GeneHarbor Corporation Information 91
11.1.2 GeneHarbor Overview 91
11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92
11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92
11.1.5 GeneHarbor Recent Developments 93
11.2 Herbalmax 93
11.2.1 Herbalmax Corporation Information 93
11.2.2 Herbalmax Overview 93
11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94
11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94
11.3 Genex Formulas 95
11.3.1 Genex Formulas Corporation Information 95
11.3.2 Genex Formulas Overview 95
11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96
11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96
11.4 Shinkowa Pharmaceutical 97
11.4.1 Shinkowa Pharmaceutical Corporation Information 97
11.4.2 Shinkowa Pharmaceutical Overview 97
11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98
11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98
11.4.5 Shinkowa Pharmaceutical Recent Developments 98
11.5 Maac10 Formulas 99
11.5.1 Maac10 Formulas Corporation Information 99
11.5.2 Maac10 Formulas Overview 99
11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100
11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100
11.6 EffePharm 101
11.6.1 EffePharm Corporation Information 101
11.6.2 EffePharm Overview 101
11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101
11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102
11.7 Bontac 102
11.7.1 Bontac Corporation Information 102
11.7.2 Bontac Overview 103
11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103
11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104
11.7.5 Bontac Recent Developments 104
11.8 CELFULL 104
11.8.1 CELFULL Corporation Information 104
11.8.2 CELFULL Overview 105
11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105
11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105
11.9 Kingdomway 106
11.9.1 Kingdomway Corporation Information 106
11.9.2 Kingdomway Overview 106
11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107
11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109
12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109
12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109
12.2.1 Key Raw Materials 109
12.2.2 Raw Materials Key Suppliers 109
12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110
12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110
12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110
12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112
12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113
13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114
13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114
13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114
13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115
13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115
14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116
15 APPENDIX 117
15.1 Research Methodology 117
15.1.1 Methodology/Research Approach 117
15.1.2 Data Source 120
15.2 Author Details 122
15.3 Disclaimer 123

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market
The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.

Global Beta-Nicotinamide Mononucleotide (NMN) Scope and Segment
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Segment by Type
Content ≥98%
Content ＜98%

Segment by Application
Health Care Products
Cosmetics
Others

Segment by Region
North America
U.S.
Canada

Asia-Pacific
China
Japan
Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil
Argentina

Middle East and Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1
1.2 Market by Type 1
1.3 Market by Application 2
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2
1.3.2 Health Care Products 3
1.3.3 Cosmetics 4
1.4 Study Objectives 4
1.5 Years Considered 5
2 EXECUTIVE SUMMARY 6
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7
2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8
2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9
2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9
2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10
2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12
2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12
2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12
2.6 North America 13
2.7 Europe 14
2.8 Asia-Pacific 15
2.9 Latin America 16
2.10 Middle East and Africa 17
3 COMPETITION BY MANUFACTURERS 19
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19
3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19
3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20
3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21
3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21
3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22
3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23
3.4 Analysis of Competitive Landscape 24
3.4.1 Manufacturers Market Concentration Ratio (CR5) 24
3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25
3.5 Mergers & Acquisitions, Expansion Plans 26
4 MARKET SIZE BY TYPE 27
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27
4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29
4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29
4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30
4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30
4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30
5 MARKET SIZE BY APPLICATION 32
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36
5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36
5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36
6 NORTH AMERICA 37
6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37
6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37
6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38
6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39
6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39
6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40
6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42
6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42
6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43
6.3.3 U.S. 44
6.3.4 Canada 45
7 EUROPE 46
7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46
7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46
7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47
7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48
7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48
7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49
7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51
7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51
7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52
7.3.3 Germany 54
7.3.4 France 55
7.3.5 U.K. 55
7.3.6 Italy 56
7.3.7 Russia 56
8 ASIA PACIFIC 57
8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57
8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57
8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58
8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59
8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59
8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60
8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62
8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62
8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63
8.3.3 China 65
8.3.4 Japan 66
8.3.5 Korea 67
8.3.6 India 68
8.3.7 Australia 69
8.3.8 Southeast Asia 70
9 LATIN AMERICA 71
9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71
9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71
9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72
9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73
9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73
9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74
9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76
9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76
9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77
9.3.3 Mexico 79
9.3.4 Brazil 80
9.3.5 Argentina 81
10 MIDDLE EAST AND AFRICA 82
10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82
10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82
10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83
10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84
10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84
10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85
10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87
10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87
10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88
10.3.3 Middle East 89
10.3.4 Africa 90
11 CORPORATE PROFILE 91
11.1 GeneHarbor 91
11.1.1 GeneHarbor Corporation Information 91
11.1.2 GeneHarbor Overview 91
11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92
11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92
11.1.5 GeneHarbor Recent Developments 93
11.2 Herbalmax 93
11.2.1 Herbalmax Corporation Information 93
11.2.2 Herbalmax Overview 93
11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94
11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94
11.3 Genex Formulas 95
11.3.1 Genex Formulas Corporation Information 95
11.3.2 Genex Formulas Overview 95
11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96
11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96
11.4 Shinkowa Pharmaceutical 97
11.4.1 Shinkowa Pharmaceutical Corporation Information 97
11.4.2 Shinkowa Pharmaceutical Overview 97
11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98
11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98
11.4.5 Shinkowa Pharmaceutical Recent Developments 98
11.5 Maac10 Formulas 99
11.5.1 Maac10 Formulas Corporation Information 99
11.5.2 Maac10 Formulas Overview 99
11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100
11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100
11.6 EffePharm 101
11.6.1 EffePharm Corporation Information 101
11.6.2 EffePharm Overview 101
11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101
11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102
11.7 Bontac 102
11.7.1 Bontac Corporation Information 102
11.7.2 Bontac Overview 103
11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103
11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104
11.7.5 Bontac Recent Developments 104
11.8 CELFULL 104
11.8.1 CELFULL Corporation Information 104
11.8.2 CELFULL Overview 105
11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105
11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105
11.9 Kingdomway 106
11.9.1 Kingdomway Corporation Information 106
11.9.2 Kingdomway Overview 106
11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107
11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109
12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109
12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109
12.2.1 Key Raw Materials 109
12.2.2 Raw Materials Key Suppliers 109
12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110
12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110
12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110
12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112
12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113
13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114
13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114
13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114
13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115
13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115
14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116
15 APPENDIX 117
15.1 Research Methodology 117
15.1.1 Methodology/Research Approach 117
15.1.2 Data Source 120
15.2 Author Details 122
15.3 Disclaimer 123

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630